Pharmaceuticals

Global and China Drugs for Treatment of Primary Hypercholesterolemia Research Report 2015 to 2021

  • QYR604258
  • 123 Pages
  • June 2016
  • Pharmaceuticals
China Drugs for Treatment of Primary Hypercholesterolemia Research Report 2015 to 2021
Hard Copy: 2750 USD
PDF Copy (single user): 2750 USD
Enterprise wide License: 5500 USD
Pages: 123
Tables and Figures: 156
Published Date: June 2016
Publisher: QYR Medical Research Center
Contact: Mr. Zhang Dong 86-10-82945717; 86-13811796901, sales@qyresearch.com

The global Drugs for Treatment of Primary hypercholesterolemia market was valued at USD 78.47 Billion in 2015, and is projected to reach USD 86.92 Billion by 2021, at a CAGR of 2.07% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Primary hypercholesterolemia in Global and China market, including Rosuvastatin Calcium Tablets, Atorvastatin Calcium Tablets, Simvastatin Tablets, Simvastatin Pills, Fluvastatin Sodium Capsules, Pravastatin Sodium Capsule, Rosuvastatin Calcium Capsules, Atorvastatin Calcium Capsules and Pravastatin Sodium Tablets, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Primary hypercholesterolemia in America, Established ROW, Western Europe, Emerging Markets, Russia and China, forecast to 2021, from 2015.The sales mainly credit at Crestor, which took up 63.94% market share in 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Primary hypercholesterolemia, revenue and market share, for key manufacturers. The main manufacturers as follows: AstraZeneca, Pfizer, Lek Pharmaceuticals, MSD TECHNOLOGY SINGAPORE PTE LTD, Merck Sharp & Dohme (Australia) Pty. Ltd., Novartis, Bristol-Myers Squibb, Simcere, SL PHARM, Cinmed Pharmaceutical, HISUN, Livzon Pharmaceutical Group and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Primary hypercholesterolemia in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Primary hypercholesterolemia in major applications.

With 123 pages, 156 charts and eight chapters, to display the market present situation and future, clearly and deeply.


Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>